POCARED Diagnostics

company

About

POCARED Diagnostics is revolutionizing infections disease practice with culture-free microbiology.

  • 11 - 50

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
€22M
Industries
Biotechnology,Health Care,Health Diagnostics
Founded date
Jan 1, 2004
Number Of Employee
11 - 50
Operating Status
Active

POCARED DiagnosticsTM is an in-vitro diagnostics company developing a next generation microbiology platform. POCAREDTM is revolutionizing infectious disease diagnosis with CULTURE-FREE MicrobiologyTM POCARED’sTM P-1000TM; a platform that is fully automated, reagent free, real time, and easy to operate. POCARED'TM saves several critical days in result reporting by providing multi-source detection, quantification and species identification results for bacteria and yeast in few minutes, directly from the specimen.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€22M
POCARED Diagnostics has raised a total of €22M in funding over 2 rounds. Their latest funding was raised on May 12, 2022 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 12, 2022 Debt Financing €22M 1 European Investment Bank Detail

Investors

Number of Lead Investors
Number of Investors
1
1
POCARED Diagnostics is funded by 1 investors. European Investment Bank are the most recent investors.
Investor Name Lead Investor Funding Round
European Investment Bank Yes Debt Financing